725 related articles for article (PubMed ID: 28056660)
21. The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
Minakata M; Ito M; Kishi T; Hada M; Masaki Y; Nakamura T; Kousaka K; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Akamizu T; Miyauchi A
Endocr J; 2022 Feb; 69(2):165-172. PubMed ID: 34526424
[TBL] [Abstract][Full Text] [Related]
22. Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients.
Gullo D; Latina A; Frasca F; Le Moli R; Pellegriti G; Vigneri R
PLoS One; 2011; 6(8):e22552. PubMed ID: 21829633
[TBL] [Abstract][Full Text] [Related]
23. THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga WM
Eur J Endocrinol; 2017 Dec; 177(6):R287-R296. PubMed ID: 28855267
[TBL] [Abstract][Full Text] [Related]
24. Effects on bone mineral density by treatment of benign nodular goiter with mildly suppressive doses of L-thyroxine in a cohort women study.
Appetecchia M
Horm Res; 2005; 64(6):293-8. PubMed ID: 16269872
[TBL] [Abstract][Full Text] [Related]
25. Is a Normal TSH Synonymous With "Euthyroidism" in Levothyroxine Monotherapy?
Peterson SJ; McAninch EA; Bianco AC
J Clin Endocrinol Metab; 2016 Dec; 101(12):4964-4973. PubMed ID: 27700539
[TBL] [Abstract][Full Text] [Related]
26. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
[TBL] [Abstract][Full Text] [Related]
27. Factors related to clinical hypothyroid severity in thyroid cancer patients after thyroid hormone withdrawal.
Huang SC; Wu VC; Lin SY; Sheu WH; Song YM; Lin YH; Wu CC; Chang WD
Thyroid; 2009 Jan; 19(1):13-20. PubMed ID: 19072673
[TBL] [Abstract][Full Text] [Related]
28. Unusual malabsorption of levothyroxine.
Jauk B; Mikosch P; Gallowitsch HJ; Kresnik E; Molnar M; Gomez I; Lind P
Thyroid; 2000 Jan; 10(1):93-5. PubMed ID: 10691319
[TBL] [Abstract][Full Text] [Related]
29. DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.
Castagna MG; Dentice M; Cantara S; Ambrosio R; Maino F; Porcelli T; Marzocchi C; Garbi C; Pacini F; Salvatore D
J Clin Endocrinol Metab; 2017 May; 102(5):1623-1630. PubMed ID: 28324063
[TBL] [Abstract][Full Text] [Related]
30. Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer.
Jonklaas J; Nsouli-Maktabi H; Soldin SJ
Thyroid; 2008 Sep; 18(9):943-52. PubMed ID: 18788918
[TBL] [Abstract][Full Text] [Related]
31. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
[TBL] [Abstract][Full Text] [Related]
32. Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
Papadakis G; Kalaitzidou S; Triantafillou E; Drosou A; Kakava K; Dogkas N; Pappa T; Kaltzidou V; Tertipi A; Villiotou V; Pappas A
Anticancer Res; 2015 Dec; 35(12):6933-40. PubMed ID: 26637919
[TBL] [Abstract][Full Text] [Related]
33. Thyroid function from birth to adolescence in Prader-Willi syndrome.
Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
[TBL] [Abstract][Full Text] [Related]
34. Seasonal variations in TSH serum levels in athyreotic patients under L-thyroxine replacement monotherapy.
Gullo D; Latina A; Frasca F; Squatrito S; Belfiore A; Vigneri R
Clin Endocrinol (Oxf); 2017 Aug; 87(2):207-215. PubMed ID: 28398655
[TBL] [Abstract][Full Text] [Related]
35. Differentiated thyroid cancer in two patients with resistance to thyroid hormone.
Paragliola RM; Lovicu RM; Locantore P; Senes P; Concolino P; Capoluongo E; Pontecorvi A; Corsello SM
Thyroid; 2011 Jul; 21(7):793-7. PubMed ID: 21649470
[TBL] [Abstract][Full Text] [Related]
36. Effects of Thyrotropin on Peripheral Thyroid Hormone Metabolism and Serum Lipids.
Beukhof CM; Massolt ET; Visser TJ; Korevaar TIM; Medici M; de Herder WW; Roeters van Lennep JE; Mulder MT; de Rijke YB; Reiners C; Verburg FA; Peeters RP
Thyroid; 2018 Feb; 28(2):168-174. PubMed ID: 29316865
[TBL] [Abstract][Full Text] [Related]
37. Body Composition, Resting Energy Expenditure, and Metabolic Changes in Women Diagnosed with Differentiated Thyroid Carcinoma.
Izkhakov E; Vaisman N; Barnes S; Barchana M; Stern N; Keinan-Boker L
Thyroid; 2019 Aug; 29(8):1044-1051. PubMed ID: 31088334
[No Abstract] [Full Text] [Related]
38. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients.
Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK
Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668
[TBL] [Abstract][Full Text] [Related]
39. Effects of Long-Term Combination LT4 and LT3 Therapy for Improving Hypothyroidism and Overall Quality of Life.
Tariq A; Wert Y; Cheriyath P; Joshi R
South Med J; 2018 Jun; 111(6):363-369. PubMed ID: 29863229
[TBL] [Abstract][Full Text] [Related]
40. Changes in TSH levels in athyreotic patients with differentiated thyroid cancer during levothyroxine therapy: influence on dose adjustments.
Grani G; Tumino D; Ramundo V; Ciotti L; Lomonaco C; Armillotta M; Falcone R; Lucia P; Maranghi M; Filetti S; Durante C
J Endocrinol Invest; 2019 Dec; 42(12):1485-1490. PubMed ID: 31203497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]